-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
R&D base
21
2026-04
On April 21, Shandong Lino Pharmaceutical Co., Ltd., a wholly owned subsidiary of Shandong Keyuan Pharmaceutical Co.,Ltd. (stock code: 301281.SZ), and Hubei General Pharmaceutical Co., Ltd. held a grand strategic cooperation signing ceremony. The two parties will join forces and complement each other’s strengths to deepen comprehensive cooperation in areas such as product distribution, industrial chain synergy, and medical terminal coverage, thereby focusing on serving the “Healthy China” strategy and jointly building a new pattern of high-quality development in the pharmaceutical industry.
2026-04-21
14
2026-04
On April 14, in-cosmetics Global 2026—the premier European trade show for cosmetic ingredients—kicked off with great fanfare at the Paris Expo Porte de Versailles in France. As a leading player in the pharmaceutical-grade active ingredient segment, Keyuan Pharmaceutical (stock code: 301281.SZ) showcased its full portfolio of high-purity, pharmaceutical-grade cosmetic ingredients, bioactive functional ingredients, and customized solutions, thereby forging a bridge for collaboration between China’s pharmaceutical industry and the global beauty market.
2026-04-14
08
2026-04
With the vigorous spring breeze ushering in a new journey, we are uniting our hearts and pooling our strengths to tackle the toughest challenges once again. On April 8, Keyuan Group (Keyuan Pharmaceutical, stock code 301281.SZ; Linuo Pharmaceutical) solemnly convened the “First-Quarter Strong Start and Second-Quarter Mobilization Conference.” Chairman Li Hongfu, President Wei Zhiguo, other members of the management team, heads of all business units and regional divisions within the Marketing Center, as well as representatives from relevant functional departments, gathered to conduct a comprehensive review of the first-quarter marketing performance, outline the key tasks for the second quarter and the full year, and sound the rallying call for an all-out sprint toward achieving the year’s targets.
2026-04-08
27
2026-03
From March 26 to 27, a delegation led by ELSHEIKH Tarek, Global Director of Resource Development at global beauty giant L’Oréal Group, visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. Li Hongfu, Chairman of Keyuan Pharmaceutical, together with heads of relevant departments, extended a warm welcome. The two sides held in-depth discussions on key issues such as deepening strategic cooperation and jointly expanding into global markets, reaching multiple agreements.
2026-03-27
13
2026-03
As the spring breeze brings warmth and vegetation begins to stir, on the eve of the 48th Arbor Day, Keyuan Pharmaceutical (stock code: 301281.SZ) warmly launched a voluntary tree‑planting initiative, pooling efforts to add new greenery and empower ecological beauty. Employee representatives from various plants and functional departments gathered together, putting the concept of green development into practice through concrete actions and adding a fresh touch of green to the factory grounds.
2026-03-13
10
2026-03
To keep pace with the rapid advancement of AI technology, foster deep integration between AI and pharmaceutical operations, and comprehensively enhance the AI application capabilities of all employees, Keyuan Group organized a series of AI application training sessions for its entire workforce on March 10. Employees of Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical participated in this training, jointly unlocking new skills in AI tool applications and strengthening the talent foundation for the company’s digital and intelligent transformation.
2026-03-10
07
2026-03
The warm spring breeze of March warms hearts, and the graceful elegance of women blossoms anew. As the International Women’s Day on March 8, 2026 approaches, to honor all female employees for their dedication and commitment, enrich their cultural lives, strengthen team cohesion, and foster a strong atmosphere of respect and care for women, Keyuan Pharmaceutical held a fun-filled event for female employees on March 7, themed “The Spring Breeze Is Like You—Shining Brightly.” All the company’s female employees gathered together joyfully, spending a special and delightful time together through lively competitions.
2026-03-07
27
2026-02
From February 26 to 27, Professor Chen Shouwen from Hubei University and his delegation visited Kexuan Pharmaceutical for a visit and exchange. Li Hongfu, Chairman of Kexuan Pharmaceutical, along with his team, provided full-time accompaniment throughout the visit. The two sides held an in-depth discussion on topics including core product R&D processes, market strategies, and industry-university collaboration.
2026-02-27
23
2026-02
The rugged pass ahead seems as solid as iron, yet today we take a step forward and start anew. On February 23, Keyuan Group (Keyuan Pharmaceutical 301281.SZ, Linuo Pharmaceutical) successfully held its 2026 Marketing Special Conference—the “First Lesson of the New Year”—marking a strong start to the resumption of work. All members of the management team, including Chairman Li Hongfu and President Wei Zhiguo, as well as heads of various business units, functional departments, and core key employees, participated in the event. With the theme “Strategic Leadership, Uniting Hearts and Gathering Strength, Tackling Tough Challenges and Breaking Impasses,” the conference set forth the core objectives for 2026 marketing efforts, carefully planned and laid out the year’s overall marketing strategy, and sounded the clarion call for vigorous advancement as we resume work and production in the new year.
2026-02-23
10
2026-02
On February 10, the bidding process for the new round of follow-up procurement of drugs from the first to eighth batches of nationally centralized drug procurement yielded preliminary winning results. This round of follow-up procurement was jointly organized by the National Healthcare Security Administration, with Jiangsu, Henan, and Guangdong provinces serving as joint lead agencies, and was implemented nationwide in a coordinated manner. It achieved “three unifications”—unified procurement rules, standardized operational procedures, and a consistent market scope—marking an important milestone in deepening and systematizing the reform of centralized drug procurement.
2026-02-10
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline